תוצאות חיפוש מחבר

1

AJRCCM: 100-Y<scp>ear</scp> A<scp>nniversary</scp>.The Shifting Landscape for Lung Cancer: Past, Present, and Future מאת Anil Vachani, Lecia V. Sequist, Avrum Spira

יצא לאור 2017

קבל טקסט מלא
Revisão

הוספה למועדפים

שמור ב:
2

Genetic Changes in Squamous Cell Lung Cancer: A Review מאת Rebecca S. Heist, Lecia V. Sequist, Jeffrey A. Engelman

יצא לאור 2012

קבל טקסט מלא קבל טקסט מלא
Revisão

הוספה למועדפים

שמור ב:
3

TargetingEGFRExon 20 Insertions in Non–Small Cell Lung Cancer: Recent Advances and Clinical Updates מאת Catherine B. Meador, Lecia V. Sequist, Zofia Piotrowska

יצא לאור 2021

קבל טקסט מלא קבל טקסט מלא
Revisão

הוספה למועדפים

שמור ב:
4

Update to Rociletinib Data with the RECIST Confirmed Response Rate מאת Lecia V. Sequist, Jean‐Charles Soria, D. Ross Camidge

יצא לאור 2016

קבל טקסט מלא קבל טקסט מלא
Carta

הוספה למועדפים

שמור ב:
5

Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management מאת Alissa J. Cooper, Lecia V. Sequist, W. Marston Linehan

יצא לאור 2022

קבל טקסט מלא
Revisão

הוספה למועדפים

שמור ב:
6

Response to Osimertinib in an EGFR Exon 20 Insertion-Positive Lung Adenocarcinoma מאת Zofia Piotrowska, Florian J. Fintelmann, Lecia V. Sequist, Balkrishna Jahagirdar

יצא לאור 2018

קבל טקסט מלא קבל טקסט מלא
Carta

הוספה למועדפים

שמור ב:
7

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin מאת Matthew G. Oser, Matthew J. Niederst, Lecia V. Sequist, Jeffrey A. Engelman

יצא לאור 2015

קבל טקסט מלא
Revisão

הוספה למועדפים

שמור ב:
8

The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients מאת Lecia V. Sequist, Sunitha Nagrath, Mehmet Toner, Daniel A. Haber, Thomas J. Lynch

יצא לאור 2009

קבל טקסט מלא קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:
9

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status? מאת Subba R. Digumarthy, Atul Padole, Roberto Lo Gullo, Lecia V. Sequist, Mannudeep K. Kalra

יצא לאור 2019

קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:
10

Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer מאת Meghan Campo, H. Al-Halabi, Melin J. Khandekar, Alice T. Shaw, Lecia V. Sequist, Henning Willers

יצא לאור 2016

קבל טקסט מלא קבל טקסט מלא
Revisão

הוספה למועדפים

שמור ב:
11

Pattern of Failure Analysis in Metastatic EGFR-Mutant Lung Cancer Treated with Tyrosine Kinase Inhibitors to Identify Candidates for Consolidation Stereotactic Body Radiation Thera... מאת H. Al-Halabi, Karl Sayegh, Subba R. Digamurthy, Andrzej Niemierko, Zofia Piotrowska, Henning Willers, Lecia V. Sequist

יצא לאור 2015

קבל טקסט מלא קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:
12

Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib מאת Lecia V. Sequist, Zofia Piotrowska, Matthew J. Niederst, Rebecca S. Heist, Subba R. Digumarthy, Alice T. Shaw, Jeffrey A. Engelman

יצא לאור 2015

קבל טקסט מלא קבל טקסט מלא
Carta

הוספה למועדפים

שמור ב:
13

Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors מאת Sarah B. Goldberg, Geoffrey R. Oxnard, Subba R. Digumarthy, Alona Muzikansky, David M. Jackman, Inga T. Lennes, Lecia V. Sequist

יצא לאור 2013

קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:
14

Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT? מאת Subba R. Digumarthy, Atul Padole, Shivam Rastogi, Melissa C. Price, Meghan J. Mooradian, Lecia V. Sequist, Mannudeep K. Kalra

יצא לאור 2019

קבל טקסט מלא קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:
15

FGFR1 Amplification in Squamous Cell Carcinoma of The Lung מאת Rebecca S. Heist, Mari Mino‐Kenudson, Lecia V. Sequist, Swathi Tammireddy, L Morrissey, David C. Christiani, Jeffrey A. Engelman, A. John Iafrate

יצא לאור 2012

קבל טקסט מלא קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:
16

Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer מאת Raymond H. Mak, Subba R. Digumarthy, Alona Muzikansky, Jeffrey A. Engelman, Jo-Anne O. Shepard, Noah C. Choi, Lecia V. Sequist

יצא לאור 2011

קבל טקסט מלא קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:
17

Delay of treatment change after objective progression on first‐line erlotinib in epidermal growth factor receptor‐mutant lung cancer מאת Peter Lo, Suzanne E. Dahlberg, Mizuki Nishino, Bruce E. Johnson, Lecia V. Sequist, David M. Jackman, Pasi A. Jänne, Geoffrey R. Oxnard

יצא לאור 2015

קבל טקסט מלא קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:
18

The Allelic Context of the C797S Mutation Acquired upon Treatment with Third-Generation EGFR Inhibitors Impacts Sensitivity to Subsequent Treatment Strategies מאת Matthew J. Niederst, Haichuan Hu, Hillary E. Mulvey, Elizabeth L. Lockerman, Angel R. Garcia, Zofia Piotrowska, Lecia V. Sequist, Jeffrey A. Engelman

יצא לאור 2015

קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:
19

EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer מאת April F. Eichler, Kristopher T. Kahle, D. L. Wang, Victoria A. Joshi, Henning Willers, J. A. Engelman, Thomas J. Lynch, Lecia V. Sequist

יצא לאור 2010

קבל טקסט מלא קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:
20

Outcomes After Combined Modality Therapy forEGFR-Mutant and Wild-Type Locally Advanced NSCLC מאת Raymond H. Mak, Elizabeth Doran, Alona Muzikansky, Josephine Kang, Joel W. Neal, Noah C. Choi, Henning Willers, David M. Jackman, Lecia V. Sequist

יצא לאור 2011

קבל טקסט מלא קבל טקסט מלא
Artigo

הוספה למועדפים

שמור ב:

<i>AJRCCM</i>: 100-Y<scp>ear</scp> A<scp>nniversary</scp>.The Shifting Landscape for Lung Cancer: Past, Present, and Future מאת Anil Vachani, Lecia V. Sequist, Avrum Spira

Genetic Changes in Squamous Cell Lung Cancer: A Review מאת Rebecca S. Heist, Lecia V. Sequist, Jeffrey A. Engelman

Targeting<i>EGFR</i>Exon 20 Insertions in Non–Small Cell Lung Cancer: Recent Advances and Clinical Updates מאת Catherine B. Meador, Lecia V. Sequist, Zofia Piotrowska

Update to Rociletinib Data with the RECIST Confirmed Response Rate מאת Lecia V. Sequist, Jean‐Charles Soria, D. Ross Camidge

Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management מאת Alissa J. Cooper, Lecia V. Sequist, W. Marston Linehan

Response to Osimertinib in an EGFR Exon 20 Insertion-Positive Lung Adenocarcinoma מאת Zofia Piotrowska, Florian J. Fintelmann, Lecia V. Sequist, Balkrishna Jahagirdar

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin מאת Matthew G. Oser, Matthew J. Niederst, Lecia V. Sequist, Jeffrey A. Engelman

The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients מאת Lecia V. Sequist, Sunitha Nagrath, Mehmet Toner, Daniel A. Haber, Thomas J. Lynch

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status? מאת Subba R. Digumarthy, Atul Padole, Roberto Lo Gullo, Lecia V. Sequist, Mannudeep K. Kalra

Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer מאת Meghan Campo, H. Al-Halabi, Melin J. Khandekar, Alice T. Shaw, Lecia V. Sequist, Henning Willers

Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib מאת Lecia V. Sequist, Zofia Piotrowska, Matthew J. Niederst, Rebecca S. Heist, Subba R. Digumarthy, Alice T. Shaw, Jeffrey A. Engelman

Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors מאת Sarah B. Goldberg, Geoffrey R. Oxnard, Subba R. Digumarthy, Alona Muzikansky, David M. Jackman, Inga T. Lennes, Lecia V. Sequist

Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT? מאת Subba R. Digumarthy, Atul Padole, Shivam Rastogi, Melissa C. Price, Meghan J. Mooradian, Lecia V. Sequist, Mannudeep K. Kalra

FGFR1 Amplification in Squamous Cell Carcinoma of The Lung מאת Rebecca S. Heist, Mari Mino‐Kenudson, Lecia V. Sequist, Swathi Tammireddy, L Morrissey, David C. Christiani, Jeffrey A. Engelman, A. John Iafrate

Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer מאת Raymond H. Mak, Subba R. Digumarthy, Alona Muzikansky, Jeffrey A. Engelman, Jo-Anne O. Shepard, Noah C. Choi, Lecia V. Sequist

Delay of treatment change after objective progression on first‐line erlotinib in epidermal growth factor receptor‐mutant lung cancer מאת Peter Lo, Suzanne E. Dahlberg, Mizuki Nishino, Bruce E. Johnson, Lecia V. Sequist, David M. Jackman, Pasi A. Jänne, Geoffrey R. Oxnard

EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer מאת April F. Eichler, Kristopher T. Kahle, D. L. Wang, Victoria A. Joshi, Henning Willers, J. A. Engelman, Thomas J. Lynch, Lecia V. Sequist

Outcomes After Combined Modality Therapy for<i>EGFR</i>-Mutant and Wild-Type Locally Advanced NSCLC מאת Raymond H. Mak, Elizabeth Doran, Alona Muzikansky, Josephine Kang, Joel W. Neal, Noah C. Choi, Henning Willers, David M. Jackman, Lecia V. Sequist

תוצאות חיפוש - Lecia V. Sequist

<i>AJRCCM</i>: 100-Y<scp>ear</scp> A<scp>nniversary</scp>.The Shifting Landscape for Lung Cancer: Past, Present, and Future מאת Anil Vachani, Lecia V. Sequist, Avrum Spira

Genetic Changes in Squamous Cell Lung Cancer: A Review מאת Rebecca S. Heist, Lecia V. Sequist, Jeffrey A. Engelman

Targeting<i>EGFR</i>Exon 20 Insertions in Non–Small Cell Lung Cancer: Recent Advances and Clinical Updates מאת Catherine B. Meador, Lecia V. Sequist, Zofia Piotrowska

Update to Rociletinib Data with the RECIST Confirmed Response Rate מאת Lecia V. Sequist, Jean‐Charles Soria, D. Ross Camidge

Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management מאת Alissa J. Cooper, Lecia V. Sequist, W. Marston Linehan

Response to Osimertinib in an EGFR Exon 20 Insertion-Positive Lung Adenocarcinoma מאת Zofia Piotrowska, Florian J. Fintelmann, Lecia V. Sequist, Balkrishna Jahagirdar

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin מאת Matthew G. Oser, Matthew J. Niederst, Lecia V. Sequist, Jeffrey A. Engelman

The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients מאת Lecia V. Sequist, Sunitha Nagrath, Mehmet Toner, Daniel A. Haber, Thomas J. Lynch

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status? מאת Subba R. Digumarthy, Atul Padole, Roberto Lo Gullo, Lecia V. Sequist, Mannudeep K. Kalra

Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer מאת Meghan Campo, H. Al-Halabi, Melin J. Khandekar, Alice T. Shaw, Lecia V. Sequist, Henning Willers

Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib מאת Lecia V. Sequist, Zofia Piotrowska, Matthew J. Niederst, Rebecca S. Heist, Subba R. Digumarthy, Alice T. Shaw, Jeffrey A. Engelman

Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors מאת Sarah B. Goldberg, Geoffrey R. Oxnard, Subba R. Digumarthy, Alona Muzikansky, David M. Jackman, Inga T. Lennes, Lecia V. Sequist

Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT? מאת Subba R. Digumarthy, Atul Padole, Shivam Rastogi, Melissa C. Price, Meghan J. Mooradian, Lecia V. Sequist, Mannudeep K. Kalra

FGFR1 Amplification in Squamous Cell Carcinoma of The Lung מאת Rebecca S. Heist, Mari Mino‐Kenudson, Lecia V. Sequist, Swathi Tammireddy, L Morrissey, David C. Christiani, Jeffrey A. Engelman, A. John Iafrate

Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer מאת Raymond H. Mak, Subba R. Digumarthy, Alona Muzikansky, Jeffrey A. Engelman, Jo-Anne O. Shepard, Noah C. Choi, Lecia V. Sequist

Delay of treatment change after objective progression on first‐line erlotinib in epidermal growth factor receptor‐mutant lung cancer מאת Peter Lo, Suzanne E. Dahlberg, Mizuki Nishino, Bruce E. Johnson, Lecia V. Sequist, David M. Jackman, Pasi A. Jänne, Geoffrey R. Oxnard

EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer מאת April F. Eichler, Kristopher T. Kahle, D. L. Wang, Victoria A. Joshi, Henning Willers, J. A. Engelman, Thomas J. Lynch, Lecia V. Sequist

Outcomes After Combined Modality Therapy for<i>EGFR</i>-Mutant and Wild-Type Locally Advanced NSCLC מאת Raymond H. Mak, Elizabeth Doran, Alona Muzikansky, Josephine Kang, Joel W. Neal, Noah C. Choi, Henning Willers, David M. Jackman, Lecia V. Sequist

כלי חיפוש:

נושאים קשורים